MAPT and Alzheimer disease: To check whether the new iron-related biomarkers could add significant improvements to AD early diagnosis, a step-by-step procedure was adopted, iteratively adding to the well-consolidated features (Aβ42, p-Tau, and t-Tau) also the results from s-Tf and iron content in CSF.